HomeAbacavir Lamivudine And ZidovudineAbacavir Lamivudine And Zidovudine + Dolutegravir

Does Abacavir Lamivudine And Zidovudine Interact with Dolutegravir?

Abacavir Lamivudine And Zidovudine and Dolutegravir have a unknown drug interaction according to U.S. FDA drug labeling data. Riociguat Coadministration with fixed-dose abacavir/dolutegravir/lamivudine resulted in increased riociguat exposure, which may increase the risk of riociguat adverse reactions [ see Clinical Pharmacology ( 12.3 ) ]. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Abacavir Lamivudine And Zidovudine Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Abacavir Lamivudine And Zidovudine and your doctor is considering prescribing Dolutegravir (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Abacavir Lamivudine And Zidovudine(Abacavir, Lamivudine And Zidovudine)+💊 Dolutegravir

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Drug B class
Source
FDA drug label - abacavir , lamivudine and zidovudine

What this means in plain English

Riociguat Coadministration with fixed-dose abacavir/dolutegravir/lamivudine resulted in increased riociguat exposure, which may increase the risk of riociguat adverse reactions [ see Clinical Pharmacology ( 12.3 ) ].

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Abacavir Lamivudine And Zidovudine and Dolutegravir against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.